The PharmEasy Date Will Be Updated Soon. Read the post to learn about Enfuse Solutions Limited IPO GMP.
PharmEasy IPO GMP Price, Date, Review Informatio IPO Upcoming is an online healthcare portal that caters to consumers. It offers prescription medications, diagnostic tests, and doctor consultations. Dharmil Sheth and Dr Dhaval Shah started this company in 2015. API Holdings Limited, its parent firm, manages its business.
Customers may purchase medications, medical supplies, and lab tests online with Pharmeasy. They are the most extensive digital healthcare platform, addressing consumers’ healthcare requirements through technology and fulfilment skills. They develop services and collaborate closely with pharmaceutical firms, hospitals, physicians’ offices, pharmacies, wholesalers, and diagnostic labs. With more than 22,000 pin codes, they distribute their goods to more than a thousand cities and villages. Mumbai, Pune, Gurgaon, Navi Mumbai, Kolkata, Delhi, Bengaluru, Ahmedabad, Hyderabad, Chennai, Thane, Howrah, Jaipur, Noida, Lucknow, Vadodara, & Ghaziabad are their major supply cities.
Start your investing journey today. Find the latest information on Upcoming IPOs.
Key Details Of PharmEasy IPO:
Bidding Dates
Coming Soon
Price Range
₹0 per share
Face Value
₹0 per share
GMP
₹0
PharmEasy IPO GMP
The PharmEasy IPO GMP Today is ₹0.
PharmEasy IPO Overview
PharmEasy presents a value proposition to all parties involved. The company supports 926 hospitals, 4,617 clinics and physicians that write prescriptions, 3,261 wholesalers, and 87,194 pharmacies. A total of 25 million people have registered on the Internet marketplace. They collaborate with and develop services for customers, pharmaceutical firms, distributors, pharmacies, hospitals, physicians’ offices and clinics, and diagnostic laboratories.
PharmEasy sees its supply chain as a resource and focuses on giving customers instant access to information on the company’s healthcare partners’ accurate supply and demand patterns. The PharmEasy IPO GMP Today is ₹0. In addition, the organisation provides a live, dynamic overview of its logistics network and delivery predictions for incoming orders. The company uses information from several links in the physical supply chain to estimate delivery timeframes. India’s top pharmaceutical marketplace is Pharmeasy.
PharmEasy IPO Financials
Financial year | Total Assets in Millions | Total Revenue in Millions | Profit After Tax in Millions |
FY 2021 | 49,053.44 | 29,809 | 6,410 |
FY 2020 | 5,724.75 | 10,840 | 3,350 |
PharmEasy Peer Comparison
Name of Company | Revenue |
Netmeds | $ 10.2 millions |
1mg | $ 6.5 millions |
Practo | $ 16.5 millions |
Company Profile
![Pharmeasy](https://ipoupcoming.com/wp-content/uploads/2023/09/Pharmeasy.jpg)
PharmEasy wants to use an initial public offering (IPO) to raise Rs. 6,250 crores. The business is discussing raising Rs. 1250 crores through a private placement with its bankers as part of a pre-IPO fundraising campaign. This will significantly reduce the size of the primary issue.PharmEasy is an online healthcare portal that gives users access to prescription drugs, diagnostic imaging, and medical consultations. Dr Dhaval Shah and Dharmil Sheth launched the business in 2015. This company’s parent, API Holdings Limited, oversees its activities. Digital tools and health information are available on the PharmEasy platform.
In addition, it offers goods and gadgets, diagnostic tests, treatment procedures, and teleconsultation services. Pharmeasy is an online platform that allows customers to buy pharmaceuticals, health care items, and lab testing. Using technology and fulfilment skills, they are the most extensive digital healthcare platform, meeting consumer requirements in healthcare. This facilitates API Holdings’ access to a diverse pool of national stockholders. In addition, subject to SEBI permission, the firm intends to go public and list its shares on the stock exchange.
IPO Strengths
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Customers based in the United States are heavily relied upon.
- One must abide by some rules and regulations in these nations to guarantee compliance.
- Competition from other players in the market.
PharmEasy FAQs
When will PharmEasy IPO allotment be available?
Details are not available.
Is PharmEasy generating revenue?
As per the various reports, the company has seen a growth of 220% in FY 2021. In this fiscal year, PharmEasy collected a revenue of Rs. 2,360 crores, which is massive when compared to Rs. 737.4 crores was collected in the fiscal year 2020.
What does PharmEasy do?
PharmEasy runs a healthcare e-commerce app for consumers with a wide range of facilities. Some of its significant resources include home delivery of consumer health products across various prescriptions, OTC pharmaceutical, diverse diagnostic test services, and consultation services to cater to various healthcare needs.
Is PharmEasy a startup company?
PharmEasy is a digital healthcare startup company that caters to the health needs of people. They offer services such as sample collection of diagnostic tests, teleconsultation and consumer healthcare product deliveries.
![PharmEasy](https://ipoupcoming.com/wp-content/uploads/2024/04/footer-image-2-12-1.jpg)
![PharmEasy IPO](https://ipoupcoming.com/wp-content/uploads/2024/04/footer-image-2-11-2.jpg)
Leave a Reply